A. Eikermann

1.1k total citations
10 papers, 832 citations indexed

About

A. Eikermann is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, A. Eikermann has authored 10 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 7 papers in Pathology and Forensic Medicine and 5 papers in Physiology. Recurrent topics in A. Eikermann's work include Migraine and Headache Studies (10 papers), Trigeminal Neuralgia and Treatments (7 papers) and Sympathectomy and Hyperhidrosis Treatments (5 papers). A. Eikermann is often cited by papers focused on Migraine and Headache Studies (10 papers), Trigeminal Neuralgia and Treatments (7 papers) and Sympathectomy and Hyperhidrosis Treatments (5 papers). A. Eikermann collaborates with scholars based in Germany, United States and India. A. Eikermann's co-authors include Jan Lewis Brandes, E. Anne MacGregor, HC Diener, Volker Limmroth, Zaza Katsarava, G. Fritsche, Tobias Kurth, Sebastian Schneeweiß, Stefan Evers and Rose Giammarco and has published in prestigious journals such as Neurology, Headache The Journal of Head and Face Pain and Cephalalgia.

In The Last Decade

A. Eikermann

10 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Eikermann Germany 8 776 486 332 92 72 10 832
TJ Steiner United Kingdom 8 918 1.2× 464 1.0× 291 0.9× 99 1.1× 73 1.0× 13 1.0k
R. Michael Gallagher United States 15 734 0.9× 466 1.0× 324 1.0× 114 1.2× 94 1.3× 27 858
H-C Diener Germany 9 547 0.7× 385 0.8× 269 0.8× 70 0.8× 80 1.1× 9 696
Astrid Gendolla Germany 14 701 0.9× 496 1.0× 287 0.9× 92 1.0× 71 1.0× 52 755
Morris Levin United States 15 554 0.7× 403 0.8× 202 0.6× 100 1.1× 130 1.8× 72 813
Herbert G. Markley United States 11 514 0.7× 302 0.6× 242 0.7× 72 0.8× 68 0.9× 16 670
S‐R Lu Taiwan 13 675 0.9× 441 0.9× 227 0.7× 110 1.2× 78 1.1× 13 738
BK Rasmussen Denmark 10 1.2k 1.5× 713 1.5× 463 1.4× 102 1.1× 114 1.6× 13 1.3k
Élizabeth Leroux Canada 15 661 0.9× 459 0.9× 293 0.9× 63 0.7× 63 0.9× 31 735
Steven Ascher United States 7 588 0.8× 410 0.8× 334 1.0× 73 0.8× 80 1.1× 7 739

Countries citing papers authored by A. Eikermann

Since Specialization
Citations

This map shows the geographic impact of A. Eikermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Eikermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Eikermann more than expected).

Fields of papers citing papers by A. Eikermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Eikermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Eikermann. The network helps show where A. Eikermann may publish in the future.

Co-authorship network of co-authors of A. Eikermann

This figure shows the co-authorship network connecting the top 25 collaborators of A. Eikermann. A scholar is included among the top collaborators of A. Eikermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Eikermann. A. Eikermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Diener, HC, Gennaro Bussone, A. Eikermann, et al.. (2004). Placebo-Controlled Comparison of Effervescent Acetylsalicylic Acid, Sumatriptan and Ibuprofen in the Treatment of Migraine Attacks. Cephalalgia. 24(11). 947–954. 79 indexed citations
2.
MacGregor, E. Anne, Jan Lewis Brandes, A. Eikermann, & Rose Giammarco. (2004). Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III. Current Medical Research and Opinion. 20(7). 1143–1150. 80 indexed citations
3.
Eikermann, A., et al.. (2004). [Therapeutic concepts in the treatment of headache].. PubMed. 146(13). 33–4, 36. 1 indexed citations
4.
Diener, HC, A. Eikermann, U. Gessner, et al.. (2004). Efficacy of 1,000 mg Effervescent Acetylsalicylic Acid and Sumatriptan in Treating Associated Migraine Symptoms. European Neurology. 52(1). 50–56. 38 indexed citations
5.
Katsarava, Zaza, Sebastian Schneeweiß, Tobias Kurth, et al.. (2004). Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 62(5). 788–790. 304 indexed citations
6.
Frese, Achim, A. Eikermann, K. Frese, et al.. (2003). Headache associated with sexual activity. Neurology. 61(6). 796–800. 79 indexed citations
7.
MacGregor, E. Anne, Jan Lewis Brandes, & A. Eikermann. (2003). Migraine Prevalence and Treatment Patterns: The Global Migraine and Zolmitriptan Evaluation Survey. Headache The Journal of Head and Face Pain. 43(1). 19–26. 160 indexed citations
8.
Diener, H. C., Volker Limmroth, & A. Eikermann. (2003). Neues bei Migräne und Kopfschmerzen. Aktuelle Neurologie. 30(6). 261–265. 2 indexed citations
9.
Eikermann, A. & HC Diener. (2003). Effect of Active Treatment is Lower When Using Placebo Control in Clinical Trials on Acute Therapy of Migraine. Cephalalgia. 23(5). 344–347. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026